Molecular pharming’s foot in the FDA’s door: Protalix’s trailblazing story
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular pharming’s foot in the FDA’s door: Protalix’s trailblazing story
Authors
Keywords
Plant-derived biologics, FDA-approval, Gaucher’s disease, Ebola, Molecular pharming
Journal
BIOTECHNOLOGY LETTERS
Volume 37, Issue 11, Pages 2147-2150
Publisher
Springer Nature
Online
2015-07-06
DOI
10.1007/s10529-015-1908-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential and Emerging Treatment Options for Ebola Virus Disease
- (2014) Bryan M. Bishop ANNALS OF PHARMACOTHERAPY
- Plant Molecular Pharming for the Treatment of Chronic and Infectious Diseases
- (2014) Eva Stoger et al. Annual Review of Plant Biology
- Sphingolipid lysosomal storage disorders
- (2014) Frances M. Platt NATURE
- Out of Africa — Caring for Patients with Ebola
- (2014) Eric J. Rubin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plant-based vaccines against viruses
- (2014) Edward P Rybicki Virology Journal
- US signs contract with ZMapp maker to accelerate development of the Ebola drug
- (2014) M. McCarthy BMJ-British Medical Journal
- Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses
- (2013) Maria J. Ferraz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems
- (2013) Yoram Tekoah et al. BIOSCIENCE REPORTS
- Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies
- (2013) Julian K-C. Ma et al. PLANT BIOTECHNOLOGY JOURNAL
- An adaptive data-based modeling approach for predictive control of batch systems
- (2012) Siam Aumi et al. CHEMICAL ENGINEERING SCIENCE
- What's fueling the biotech engine—2011 to 2012
- (2012) Saurabh Aggarwal NATURE BIOTECHNOLOGY
- Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease
- (2011) A. Zimran et al. BLOOD
- Clinical pharmacology as a cornerstone of orphan drug development
- (2011) Edward D. Bashaw et al. NATURE REVIEWS DRUG DISCOVERY
- Pfizer stakes a claim in plant cell–made biopharmaceuticals
- (2010) Mark Ratner NATURE BIOTECHNOLOGY
- What's fueling the biotech engine—2008
- (2009) Saurabh Aggarwal NATURE BIOTECHNOLOGY
- A Plant-Derived Recombinant Human Glucocerebrosidase Enzyme—A Preclinical and Phase I Investigation
- (2009) David Aviezer et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More